COMMUNIQUÉS West-GlobeNewswire

-
Alpha Bites: Reviews, Ingredients, Studies and Where to Buy
05/02/2025 - 19:58 -
New AFB Scholars Program Expands Opportunities for Blind Students
05/02/2025 - 21:56 -
Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
05/02/2025 - 22:00 -
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/02/2025 - 22:00 -
scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
05/02/2025 - 22:01 -
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
05/02/2025 - 22:01 -
Ascendis Pharma to Report Full Year 2024 Financial Results and Provide Business Update on February 12, 2025
05/02/2025 - 22:01 -
Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
05/02/2025 - 22:01 -
NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization
05/02/2025 - 22:04 -
Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
05/02/2025 - 22:05 -
Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update
05/02/2025 - 22:05 -
Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
05/02/2025 - 22:05 -
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
05/02/2025 - 22:05 -
Cytek Biosciences to Participate in Upcoming Investor Conferences
05/02/2025 - 22:05 -
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025
05/02/2025 - 22:05 -
Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
05/02/2025 - 22:05 -
BriaCell Therapeutics Announces Closing of Public Offering
05/02/2025 - 22:05 -
The Ensign Group Reports Fiscal Year and Fourth Quarter 2024 Results; Issues 2025 Earnings Guidance
05/02/2025 - 22:06 -
DLH Reports Fiscal 2025 First Quarter Results
05/02/2025 - 22:15
Pages